pharmaceutical research has made in the last few years enormous progress, especially in the fight against cancer. This is the good news. The less good: The developed drugs are expensive, and their Use is in many cases unclear. Only a small part of these therapies is extended according to a new study of the lives of more than three months, and the majority is more or less useless (read more about the analysis of the actual Use of cancer agents). In many cases, data is missing to be able to Use to judge.
The health insurance law stipulates that only therapies, to be paid that are effective, practical and economical. Checked and monitored, this must be, in principle, by the health insurance companies, in the field of medicines but also by the Federal government at the time of admission. You have a responsibility to the premium payers.
compensation after successful therapy would reward real Innovation.
The number of cases, however, is often too low to allow meaningful analysis. In the future we will have personalized therapies, in which no statement about the Benefits is more possible. The Federal government takes the medication but nevertheless, on the specialties list, which is why you need to be paid for by the health insurance funds and the premium payers. The insurance companies expect increase in medical costs in the next few years.
the solution to The problem lies in a price-fixing, which rewarded the success of a drug in the patient. Instead of the pharmaceutical companies to guarantee in advance a high price, could this be retrospectively compensated – then depending on how long and how well the Patient lives on.
This is the compensation to the success of the therapy would reward real Innovation and the premium payers and pension funds, be sure that you only Finance what really brings something. Already some pharmaceutical companies have indicated their willingness to do so. Switzerland with its expensive health care, it should take you at your word.
Created: 19.11.2019, 06:43 PM